Bristol-Myers Squibb Company
Antibodies conjugatable by transglutaminase and conjugates made therefrom

Last updated:

Abstract:

An antibody has at a heavy chain thereof a C-terminal extension that includes at least one glutamine that is a substrate for transglutaminase, enabling the transglutaminase-mediated preparation antibody-drug conjugates using such antibody.

Status:
Grant
Type:

Utility

Filling date:

1 Mar 2016

Issue date:

9 Jun 2020